SCHEMBL4202829

SCHEMBL4202829

CC(C)n1ccc2cc(NC(=O)OCc3ccccc3)ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ NPC1 O15118 2/20 0.52
▸ RAB9A P51151 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ ATM Q13315 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ MGLL Q99685 2/20 0.51
▸ ROCK2 O75116 1/20 0.51
▸ MAP3K5 Q99683 1/20 0.48
▸ POLB P06746 1/20 0.47
▸ ENPP2 Q13822 2/20 0.46
▸ MEN1 O00255 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ PTPN1 P18031 1/20 0.44
▸ KDM1A O60341 1/20 0.44
▸ MAOA P21397 1/20 0.44
▸ MAOB P27338 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3386295 0.82 ALDH1A1 (0.52) TP53MAPTALDH1A1SMN1; SMN2POLB
SCHEMBL9193611 0.81 SLC6A2 (0.54) TP53MAPTNPC1RAB9AALDH1A1
SCHEMBL5336933 0.80 ROCK2 (0.49) TP53MAPTNPC1RAB9AALDH1A1
SCHEMBL30207797 0.76 MGLL (0.65) TP53MAPTNPC1RAB9AALDH1A1
SCHEMBL4432278 0.76 MGLL (0.65) TP53MAPTNPC1RAB9AALDH1A1
SCHEMBL5339818 0.76 NOTUM (0.57) TP53MAPTNPC1RAB9AALDH1A1
SCHEMBL2746902 0.74 MGLL (0.62) TP53MAPTNPC1RAB9AALDH1A1
SCHEMBL7836906 0.74 ADORA2B (0.57) TP53MAPTNPC1RAB9AALDH1A1
SCHEMBL21244774 0.73 NPC1 (0.56) NPC1RAB9AMEN1KMT2AMAOA
SCHEMBL16942604 0.72 POLB (0.62) TP53MAPTNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149520-A1 OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-06-11 — — US disclosed
EP-2004640-A1 OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS Pfizer Products Inc. (US) 2008-12-24 — — EP disclosed
WO-2007091147-A1 OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS PFIZER PRODUCTS INC. (US) 2007-08-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149520-A1 OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS OXA1L, MT-ND4L, IL4I1 TP53 3885/4885MAPT 3936/4885NPC1 2334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback